Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,605 | -1,702 | -26,744 | -3,232 | -1,775 |
| Depreciation Amortization | 70 | 35 | 18,352 | 6 | 5 |
| Income taxes - deferred | N/A | N/A | 4 | N/A | N/A |
| Accounts receivable | -55 | 136 | -525 | 8 | 8 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 62 |
| Other Working Capital | -3,093 | -182 | 3,151 | 235 | -97 |
| Other Operating Activity | 55 | -136 | 514 | -19 | -80 |
| Operating Cash Flow | $-5,628 | $-1,850 | $-5,248 | $-3,002 | $-1,878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -455 | 0 | -194 | N/A | N/A |
| Net Acquisitions | N/A | -1 | -14,348 | N/A | N/A |
| Purchase Sale Intangibles | -18 | -178 | -111 | N/A | N/A |
| Other Investing Activity | 49 | -146 | -78 | 0 | 0 |
| Investing Cash Flow | $-406 | $-146 | $-14,619 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,900 | -1,900 | -1,900 |
| Common Stock Issued | 4,090 | N/A | 43,560 | 43,560 | 43,560 |
| Common Stock Repurchased | -507 | -507 | -99 | -99 | -99 |
| Other Financing Activity | -64 | -32 | -2,096 | 0 | 0 |
| Financing Cash Flow | $3,520 | $-538 | $39,465 | $41,561 | $41,561 |
| Exchange Rate Effect | 417 | 3 | 184 | -49 | -1 |
| Beginning Cash Position | 21,826 | 21,826 | 2,045 | 2,045 | 2,045 |
| End Cash Position | 19,730 | 19,294 | 21,826 | 40,556 | 41,728 |
| Net Cash Flow | $-2,097 | $-2,532 | $19,781 | $38,511 | $39,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,628 | -1,850 | -5,248 | -3,002 | -1,878 |
| Capital Expenditure | -455 | 0 | -194 | N/A | N/A |
| Free Cash Flow | -6,083 | -1,850 | -5,442 | -3,002 | -1,878 |